Adult with UC or Crohn's disease: is surgery indicated?
Decide with the IBD multidisciplinary team (gastroenterology and colorectal surgery). Involve surgery early in moderate to severe disease.
IBD Surgical Indications Algorithm (ASCRS): Adult with UC or Crohn's disease: is surgery indicated? → Before surgery: steroids, nutrition, pregnancy, ch...
Pathway Overview
17 steps
17 total
Decide with the IBD multidisciplinary team (gastroenterology and colorectal surgery). Involve surgery early in moderate to severe disease.
These factors raise the risk of leak and sepsis or put the patient outside this pathway.
For fulminant UC, toxic megacolon, perforation, refractory bleeding, or acute severe UC not responding to IV steroids and rescue therapy. Leave the rectum in situ. Decide on pouch or other reconstruction later, after recovery.
Consider extended chemical VTE prophylaxis after discharge, unless there is active bleeding or a high bleeding risk. After IPAA, look early for anastomotic leak (pelvic sepsis). Keep endoscopic surveillance of any retained rectum or pouch.
Proctocolectomy (with or without IPAA) for high-grade dysplasia or worse, persistently invisible or multifocal dysplasia, dysplasia not fully removable endoscopically, or any dysplasia with PSC. Visible low-grade dysplasia fully removed endoscopically: close surveillance.
For chronic active disease despite medical therapy, steroid dependence, or intolerance of therapy. Discuss both options: restorative (IPAA, J-pouch) and non-restorative (end ileostomy).
Free perforation: resect the perforated segment (not simple repair). Severe colitis not responding to medical therapy: total abdominal colectomy + end ileostomy. Bleeding with instability despite resuscitation: operate; targeted resection if the source is found.
Agree postoperative medical therapy with gastroenterology to treat residual disease or maintain remission. Support smoking cessation. Give VTE prophylaxis in hospital (IBD raises VTE risk) unless there is active bleeding.
No stricturoplasty with perforation, inflammatory mass, cancer, dysplasia or severe malnutrition. Inflammatory stricture: medical therapy first. Short (under 5 cm) fibrotic stricture without abscess or fistula: endoscopic balloon dilation. Dilation fails or unsuitable: limited resection (about 2 cm margins) or stricturoplasty to save bowel length.
2% to 6% of colonic Crohn's strictures contain dysplasia or cancer. If the stricture cannot be fully assessed endoscopically: resect by oncological principles. Colonic stricturoplasty is generally discouraged.
Start anti-TNF only after antibiotics and drainage. Intra-abdominal abscess: IV antibiotics; percutaneous drainage if large (under 3 cm: antibiotics alone may do). Then interval resection or medical therapy. Enteric fistula that persists despite medical therapy: resect the diseased bowel.
Ileocolic or small bowel: limited resection with about 2 cm margins, by MDT; early resection is an option in limited non-stricturing ileocaecal disease. Colon with rectal sparing: segmental colectomy (one segment) or total colectomy + ileorectal anastomosis. Rectal disease: proctocolectomy + end ileostomy.
Visible dysplasia fully removed endoscopically: surveillance. Dysplasia not removable endoscopically, also in flat mucosa, multifocal, or cancer: total colectomy or proctocolectomy by oncological principles.
ASCRS Clinical Practice Guidelines for the Surgical Management of Crohn's Disease (2020) and of Ulcerative Colitis (2026)
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
Contraindicated Populations
Applicable Regions
AU: No separate Australian surgical guideline; ASCRS and ECCO are used
EU: ECCO surgical guidelines for UC (2026) and Crohn's disease
UK: BSG IBD guideline 2019
US: ASCRS guidelines (Crohn's 2020, UC 2026)
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
The IBD Surgical Indications Algorithm (ASCRS) is a management clinical algorithm for Colorectal Surgery. It provides a structured decision tree to guide clinical decision-making, based on ASCRS Clinical Practice Guidelines for the Surgical Management of Crohn's Disease (2020) and of Ulcerative Colitis (2026).
This algorithm is based on ASCRS Clinical Practice Guidelines for the Surgical Management of Crohn's Disease (2020) and of Ulcerative Colitis (2026) (DOI: 10.1097/DCR.0000000000001716).
Known limitations include: For adults. Surgical decisions need the IBD MDT; this pathway gives indications, not operative technique.; Crohn's disease is not cured by surgery and often recurs; save bowel length. Proctocolectomy removes UC but pouch complications are common.; Perianal Crohn's disease is covered only in outline; see ASCRS 2022 anorectal fistula guideline.. Individual patient factors may require deviation from these recommendations.
In AttendMe.ai, the IBD Surgical Indications Algorithm (ASCRS) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free